Business Daily Media

Times Advertising

.

CD47 Monoclonal Antibody (AK117) Completed Phase I Dose Escalation Trial and Obtained Approval to Initiate Clinical Trial in Combination with Azacitidine for Treatment of Acute Myeloid Leukemia

  • Written by PR Newswire

HONG KONG, July 13, 2021 /PRNewswire/ -- Akeso, Inc. is pleased to announce that, CD47 monoclonal antibody (AK117), a second-generation novel drug for immuno-oncology therapy independently developed by the Company, has completed phase I dose escalation trial in Australia. AK117 resulted in no dose-limiting toxicity (DLT) and no anemia of clinical...

More Articles ...

  1. LOUIS XIII Introduces the Ultra-Rare Red Decanter N°XIII to the World's Most Exclusive Nightclubs
  2. Ribbon Launches Ribbon Connect in Australia and New Zealand for Microsoft Teams Voice Calling
  3. Guidepoint welcomes its newest global office in Sydney, Australia
  4. Hinch Distillery wins gold at International Wine and Spirit Competition 2021
  5. DroneShield (ASX:DRO) Releases Record Results
  6. The Untold Story Releases a Documentary on Prof. Ye Jiaying and Her Life of Poetry
  7. Debate is hotting up in the fledgling period pants industry as leading brands call for regulation to protect consumers from unsubstantiated performance claims
  8. YuppTV launches the top premier streaming platform SonyLIV across International Markets
  9. Thai Cabinet approves amendment to ASEAN pact, Boosting cross-border employment, training, and capacity-building in MICE
  10. OMD Sees Campaign Results Skyrocket by Using IAS Automated Tag with Google

BizCover Brings Australia’s First AI-Based Insurance Quotes to ChatGPT

Australian small business owners can now receive and compare business insurance quotes directly inside ChatGPT, in a move that signals a major shi...

VistaPrint Research Reveals Australian Small Businesses Face a Succession Cliff

With only 16% of retiring small businesses having a succession plan, tens of thousands risk closure as one in three owners nears retirement.  Ne...

Corporate volunteering grows up: how companies are shifting to meaningful, community-led impact

As workplaces settle into the new year and look for ways to strengthen culture, capability and connection, experts say corporate volunteering is e...

The Rise of Mobile-First Venues

Global Hospitality Platform, Tabit, Reveals Five Ways to Maximise Benefits of Mobile-First Systems  As Australian hospitality venues grapple with...

Why the SME is now the primary engine of global cybercrime

For over a decade, the most practical and effective advice we could offer an employee was to spot the typo. It was practical, it was free, and it wo...

Work-life Balance Key to Solving Construction Talent Shortage

New data from leading talent company Randstad Australia shows flexible working and work-life balance could be critical to addressing ongoing talen...